Arthur J. Gallagher (AJG) Form 144 Filed for 6,000-Share Sale
Rhea-AI Filing Summary
Arthur J. Gallagher & Co. (AJG) Form 144 shows a proposed sale of 6,000 shares of the issuer's common stock through Goldman Sachs & Co. LLC with an aggregate market value of $1,797,900 and an approximate sale date of 09/19/2025 on the NYSE. The filing states there are 256,400,000 shares outstanding.
The securities listed were largely acquired as compensation in the form of restricted stock units (RSUs) on dates in 2024 and 2025 (including 03/14/2025, 03/15/2025, 05/02/2024, and 08/18/2025), totaling 6,000 units by the dates shown. The filer also reported a prior sale on 09/09/2025 of 3,000 shares for gross proceeds of $899,182.50. The notice includes the filer’s representation that no undisclosed material adverse information is known.
Positive
- Full Rule 144 disclosure provided including acquisition dates, nature of acquisition (RSUs), broker, planned sale date, and outstanding shares
- Most securities were acquired as compensation (RSUs), which clarifies the origin of the shares and reduces ambiguity about related-party transfers
- Prior sale disclosed (3,000 shares on 09/09/2025 for $899,182.50), demonstrating recent transaction history
Negative
- None.
Insights
TL;DR: Small insider sale planned from RSU compensation; transaction size is immaterial relative to outstanding shares.
The filing discloses a proposed sale of 6,000 AJG shares valued at $1,797,900 and a prior sale of 3,000 shares for $899,182.50. All acquired shares listed were received as compensation via restricted stock units on specific dates in 2024 and 2025. Compared with the reported 256.4 million shares outstanding, these transactions represent a de minimis percentage, suggesting limited direct impact on market supply or valuation. Disclosure is timely and follows Rule 144 reporting requirements.
TL;DR: Form 144 properly documents insider sales tied to compensation; statement of no undisclosed material information is included.
The notice documents that the securities to be sold were acquired as compensation (RSUs) and provides acquisition dates and quantities. The filing includes the required attestation that the filer is not aware of any undisclosed material adverse information, and notes a prior sale within the past three months. From a governance perspective, the form meets procedural disclosure norms; the sizes disclosed are small relative to total outstanding shares and therefore unlikely to signal material governance concerns on their face.